Avanafil for sex pharmaceutical Male Enhancement Drug 330784-47-9

Avanafil for sex pharmaceutical Male Enhancement Drug 330784-47-9

Он регулирует гонадотропную секрецию и дифференцировку вольфова протока.:

Химическое название: Аванафил

Анализ: 99% мин.

КЕЙС: 330784-47-9

Молекулярная формула:C23H26ClN7O3

Молекулярный вес:483.9506

Персонаж: White to Off-White Cyrstalline Solid.

использование: Used for the treatment of erectile dysfunction. A phosphodiesterase 5 ингибитор.

калибровочные иглы · флакон · стерильный флакон · шприцевые фильтры Millipore 0,22 мкм Процедура: Active Pharmaceutical Ingredients; Cnbio; Erectile Dysfunction; Ингибиторы; » Жидкие инъекционные стероиды &

» Жидкие инъекционные стероиды; Фармацевтические препараты; API.

использование:
It is a development of the phosphodiesterase type 5 inhibitors, for the treatment of male sexual dysfunction, at present in the America, EU and Japan have completed phase II clinical trials, phase III clinical trials will start. The product is composed of Japanese Tanabe Pharma Company and VIVUS company development. In addition to oral dosage forms, VIVUS company is also developing Avanafil urethral administration, for not responding to oral dosage forms of patients.

Avanafil is a potent, highly selective phosphodiesterase 5 ингибитор, in vitro experiments showed that the selectivity of phosphodiesterase 5 stronger than . The compound dear compliance weak against other phosphodiesterase, and effect of adenosine receptor decreased, suggesting that the cardiovascular effects of avanafil should be weaker than .

Pre clinical study showed that avanafil and organic nitrate drugs taken in combination to reduce its on blood pressure was significantly weaker than and nitrate drugs with clothes. Кроме того, avanafil inhibition of phosphodiesterase 6 is very weak, the relevant visual disturbance suppression may the enzyme phosphodiesterase 5 inhibitor induced and other.